Galenica AG

Common Name
Galenica
Country
Switzerland
Sector
Healthcare
Industry
Medical Distribution
Employees
7,991
Ticker
GALE
Exchange
SIX SWISS EXCHANGE
Description
Galenica AG is a Swiss-based company that operates within the healthcare sector, focusing on pharmaceutical distribution, retail, and products & innovation. Its primary purpose is to deliver an integr...

Financial Statements of Galenica

Below are the financial statements of Galenica, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of CHF20242023
Net sales
3,921.08a
3,746.01a
Other income
16.22a
17.04a
Operating income
3,937.3a
3,763.05a
Cost of goods
-2,843.24a
-2,714.44a
Personnel costs
-582.73a
-550.98a
Other operating costs
-193.4a
-202.33a
Share of profit from associates and joint ventures
6.21a
6.84a
Earnings before interest, taxes, depreciation and amortisation (EBITDA)
324.14a
302.14a
Depreciation, amortisation and impairment
-109.78a
-103a
Earnings before interest and taxes (EBIT)
214.37a
199.14a
Financial income
13.38a
12.01a
Financial expenses
-13.15a
-16.2a
Earnings before taxes (EBT)
214.6a
194.95a
Income taxes
-30.9a
-29.25a
Profit from continuing operations
183.7a
165.7a
Profit from discontinued operations
-0.08a
120.45a
Net profit
183.62a
286.15a
Attributable to
Shareholders of Galenica Ltd.
182.95a
285.37a
Non-controlling interests
0.67a
0.79a
Download Data

Verified Sources Behind Galenica’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Galenica’s data sources below and access millions more through our Disclosure Search.

a. Galenica's Annual Report 2024
a. Galenica's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?